Risk Factors for Chronic Prostatitis Patients in Northwest China
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorShaanxi Provincial People's Hospital
About this trial
The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are:
* Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome * Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome.
Participants will:
* Independently receive a survey questionnaire on lifestyle, medication, and sexual habits. * Symptomatic individuals will undergo additional prostate fluid examination for diagnosis.
Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Discomfort or pain in the pelvic region or perineum;
Symptoms lasting for at least 3 months;
NIH-CPSI pain score of ≥ 4;
Controls are volunteers who do not present any prostatitis-related symptoms.
Disqualifiers
Prostate cancer;
Benign prostatic hyperplasia with a post-void residual urine volume of >50 ml;
Acute urinary tract infection.
Trial population
All patients are from Urology Clinic, while all the controls are recruited from the physical examination center of our hospital.
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
lifestyle
BehavioralLife habits and personal preferences
sexual habits
BehavioralSexual experience and activities
medication
Druguse of medication
Treatment groups
400 Participants
are divided into 2 treatment groupsGroup A: case group3 interventions
Group B: control group3 interventions
Trial outcomes
Primary outcomes
1
Odds Ratio
The ratio of exposed to unexposed individuals in the case group divided by the ratio of exposed to unexposed individuals in the control group
Time frame
baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov